Pillstats
Rx only · Capsule · Oral

Tizanidne Hydrochloride

Tizanidine Hydrochloride

4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US15 NDCs
4 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCM03BX02
RxCUI (US)57258
US makers4 labelers
Packages32
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.030$0.060$0.090$0.120Dec 2025Apr 2026Jul 2026
$0.101
Latest avg · Jul 22, 2026
+1%
Since Dec 17, 2025
4
Active US suppliers
72%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1.4K2.8K4.2K5.6K2025 Q12025 Q22025 Q32025 Q42026 Q1
2.6K
Rx · 2026 Q1
176K
Units dispensed
-44%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it4 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bryant Ranch Prepackrepackager14SUPPLYING
Ascend Laboratories, LLCunknown9SUPPLYING
Preferred Pharmaceuticals Inc.unknown6SUPPLYING
Asclemed USA, Inc.unknown3SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.